Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleOrelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study.AuthorsXu, Wei; Zhou, Keshu; Wang, Tingyu; Yang, Shenmiao; Liu, Lihong; Hu, Yu; Zhang, Wei; Ding, Kaiyang; Zhou, Jianfeng; Gao, Sujun; Xu, Bing; Zhu, Zunmin; Liu, Ting; Zhang, Huilai; Hu, Jianda; Ji, Chunyan; Wang, Shunqing; Xia, Zhongjun; Wang, Xin; Li, YanPublicationAmerican Journal of Hematology, 2023, Vol 98, Issue 4, p571ISSN0361-8609Publication typeArticleDOI10.1002/ajh.26826